- NEWS FEATURE
- Correction 29 November 2019
Who shrank the drug factory? Briefcase-sized labs could transform medicine

Credit: Rosem Morton for Nature
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 575, 274-277 (2019)
doi: https://doi.org/10.1038/d41586-019-03455-x
Updates & Corrections
-
Correction 29 November 2019: An earlier version of this story erroneously stated that an MIT project to produce biologic drugs was led by Timothy Lu. In fact, the project was led by Christopher Love with input from Lu. The article neglected to mention that this team was able to create drugs comparable to FDA-approved drugs and cite the appropriate reference. Finally, the cost estimate for medicine-on-demand systems was ambiguous.